Kathleen R Cho
Peter A. Ward Professor of Pathology
Associate Chair for Academic Affairs
Department of Pathology
Medical Director
Gynecologic Pathology
Professor of Pathology and Professor of Internal Medicine
[email protected]

Available to mentor
Kathleen R Cho
Professor
  • Center Memberships
  • Recent Publications
    • Center Memberships
    • Center Member
      Rogel Cancer Center
    Recent Publications See All Publications
    • Journal Article
      Progestogen-driven B7-H4 contributes to onco-fetal immune tolerance.
      Yu J, Yan Y, Li S, Xu Y, Parolia A, Rizvi S, Wang W, Zhai Y, Xiao R, Li X, Liao P, Zhou J, Okla K, Lin H, Lin X, Grove S, Wei S, Vatan L, Hu J, Szumilo J, Kotarski J, Freeman ZT, Skala S, Wicha M, Cho KR, Chinnaiyan AM, Schon S, Wen F, Kryczek I, Wang S, Chen L, Zou W. Cell, 2024 Aug 22; 187 (17): 4713 - 4732.e19. DOI:10.1016/j.cell.2024.06.012
      PMID: 38968937
    • Journal Article
      Cell State of Origin Impacts Development of Distinct Endometriosis-Related Ovarian Carcinoma Histotypes.
      Beddows I, Fan H, Heinze K, Johnson BK, Leonova A, Senz J, Djirackor S, Cho KR, Pearce CL, Huntsman DG, Anglesio MS, Shen H. Cancer Res, 2024 Jan 2; 84 (1): 26 - 38. DOI:10.1158/0008-5472.CAN-23-1362
      PMID: 37874327
    • Journal Article
      A framework for assessing interactions for risk stratification models: the example of ovarian cancer.
      Phung MT, Lee AW, McLean K, Anton-Culver H, Bandera EV, Carney ME, Chang-Claude J, Cramer DW, Doherty JA, Fortner RT, Goodman MT, Harris HR, Jensen A, Modugno F, Moysich KB, Pharoah PDP, Qin B, Terry KL, Titus LJ, Webb PM, Wu AH, Zeinomar N, Ziogas A, Berchuck A, Cho KR, Hanley GE, Meza R, Mukherjee B, Pike MC, Pearce CL, Trabert B. J Natl Cancer Inst, 2023 Nov 8; 115 (11): 1420 - 1426. DOI:10.1093/jnci/djad137
      PMID: 37436712
    • Journal Article
      A putative role for ALDH inhibitors and chemoprevention of BRCA-mutation-driven tumors.
      McGonigal S, Wu R, Grimley E, Turk EG, Zhai Y, Cho KR, Buckanovich RJ. Gynecol Oncol, 2023 Sep; 176: 139 - 146. DOI:10.1016/j.ygyno.2023.07.015
      PMID: 37535994
    • Chapter
      Cervical cancer
      Straubhar AM, Siedel JH. 2022 Sep 15; Tumor Board Review: Evidence-Based Case Reviews and Questions, 273 - 287.
    • Journal Article
      Metabolic collateral lethal target identification reveals MTHFD2 paralogue dependency in ovarian cancer.
      Achreja A, Yu T, Mittal A, Choppara S, Animasahun O, Nenwani M, Wuchu F, Meurs N, Mohan A, Jeon JH, Sarangi I, Jayaraman A, Owen S, Kulkarni R, Cusato M, Weinberg F, Kweon HK, Subramanian C, Wicha MS, Merajver SD, Nagrath S, Cho KR, DiFeo A, Lu X, Nagrath D. Nat Metab, 2022 Sep; 4 (9): 1119 - 1137. DOI:10.1038/s42255-022-00636-3
      PMID: 36131208
    • Presentation
      Ovarian cancer update: lessons from morphology, molecules, and mice.
      Cho KR. 2009 Nov; DOI:10.5858/133.11.1775
      PMID: 19886711
    • Presentation
      Ovarian Cancer: Employing the mouse to explore origins, provide new insights into pathogenesis, and test novel prevention strategies
      2022 Jun 1;